Proscia: Choosing the Right Digital Pathology Platform: 7 Criteria for a Better Experience with Your AI Applications
recent articles
Non-cancerous cells called stromal cells, which are found in and around prostate tumors, may be useful in assessing these tumors’ potential to spread, and may even be targets for future prostate cancer treatments, according to a study led by...
Deciphex, an innovator in Pathology AI, announces the strategic appointment of Dr. Pierre Moulin as Chief Scientific Officer. Dr Moulin, MD, PhD, MBA has established himself as a distinguished physician-scientist and pathologist, with...
Digital pathology is just pathology, but does it matter anymore?
- Advocacy
- Anatomic Pathology
- Artificial Intelligence
- Clinical Laboratories
- Current Affairs
- Data Management
- Digital Pathology News
- Education
- FDA Approval
- General Healthcare News
- Health Technology Collaboration
- Laboratory Management & Operations
- Microscopy
- Molecular Pathology
- Pathology News
- Personal
- Science
- TeleHealth
- Web/Tech
- Whole slide
Since the 1990s, many innovators to Fortune 500 and Fortune 50 companies have worked to make digital pathology a reality. While not mainstream and perhaps less than 10% of US based pathology groups have any serious implementations of digital...
Indica Labs: Learn about the exciting new features coming soon in HALO Link 4.0! HALO Link 4.0 Sneak Peek Date: 22 February 2024 Time: 8:00 – 9:00 PST | 11:00 – 12:00 EST | 16:00 – 17:00 GMT Location:...
Gestalt: Revolutionizing their Pathology Services, Sagis Adopts Digital Pathology and AI SPOKANE, Wash., Jan. 11, 2024 /PRNewswire/ -- Gestalt announces the addition of Sagis Diagnostics to their customer roster. Recognizing the evolving...
Indica Labs: Learn about the exciting new features coming soon in HALO 4.0! HALO® 4.0 Sneak Peek Date: 15 February 2024 Time: 8:00 – 9:00 PST | 11:00 – 12:00 EST | 16:00 – 17:00 GMT Location: Webinar REGISTER...
